Trade Rocket Pharmaceuticals Inc - RCKT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023624% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001401% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 6.24 |
| Open | 5.83 |
| 1-Year Change | -77.27% |
| Day's Range | 5.59 - 5.83 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 2, 2025 | 6.24 | 0.57 | 10.05% | 5.67 | 6.25 | 5.65 |
| Apr 1, 2025 | 5.75 | -0.78 | -11.94% | 6.53 | 6.56 | 5.74 |
| Mar 31, 2025 | 6.59 | -0.56 | -7.83% | 7.15 | 7.16 | 6.20 |
| Mar 28, 2025 | 7.52 | -0.23 | -2.97% | 7.75 | 7.77 | 7.43 |
| Mar 27, 2025 | 7.82 | 0.18 | 2.36% | 7.64 | 7.92 | 7.59 |
| Mar 26, 2025 | 7.63 | -0.48 | -5.92% | 8.11 | 8.14 | 7.62 |
| Mar 25, 2025 | 8.12 | -0.49 | -5.69% | 8.61 | 8.63 | 8.07 |
| Mar 24, 2025 | 8.68 | 0.29 | 3.46% | 8.39 | 8.73 | 8.35 |
| Mar 21, 2025 | 8.38 | 0.22 | 2.70% | 8.16 | 8.64 | 8.16 |
| Mar 20, 2025 | 8.26 | 0.01 | 0.12% | 8.25 | 8.52 | 8.17 |
| Mar 19, 2025 | 8.40 | 0.17 | 2.07% | 8.23 | 8.51 | 8.07 |
| Mar 18, 2025 | 8.28 | -0.17 | -2.01% | 8.45 | 8.46 | 8.19 |
| Mar 17, 2025 | 8.77 | 0.08 | 0.92% | 8.69 | 8.84 | 8.29 |
| Mar 14, 2025 | 8.70 | 0.15 | 1.75% | 8.55 | 8.74 | 8.45 |
| Mar 13, 2025 | 8.44 | -0.16 | -1.86% | 8.60 | 8.73 | 8.21 |
| Mar 12, 2025 | 8.74 | 0.09 | 1.04% | 8.65 | 8.85 | 8.20 |
| Mar 11, 2025 | 8.15 | -0.33 | -3.89% | 8.48 | 8.57 | 8.00 |
| Mar 10, 2025 | 8.53 | -0.08 | -0.93% | 8.61 | 8.74 | 8.52 |
| Mar 7, 2025 | 8.72 | -0.11 | -1.25% | 8.83 | 9.05 | 8.63 |
| Mar 6, 2025 | 8.93 | -0.02 | -0.22% | 8.95 | 9.21 | 8.75 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Rocket Pharma Company profile
About Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals, Inc. is a clinical-stage, multi-platform biotechnology company that is focused on the development of gene therapies for rare and devastating diseases. The Company’s clinical-stage ex vivo lentiviral vector (LVV) programs include: Fanconi Anemia (FA), is a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; Leukocyte Adhesion Deficiency-I (LAD-I), is a genetic disorder that causes the immune system to malfunction; Pyruvate Kinase Deficiency (PKD), is a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia, and Infantile Malignant Osteopetrosis (IMO), is a genetic disorder characterized by increased bone density and bone mass secondary to impaired bone resorption.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Rocket Pharmaceuticals Inc revenues was not reported. Net loss increased 21% to $169.1M. Higher net loss reflects research and development expense balanci increase of 15% to $113.5M (expense), General and administrative - Balancing increase of 47% to $24.5M (expense), Stock-based Compensation in SGA increase of 54% to $17.3M (expense).
| Industry: | Bio Therapeutic Drugs |
350 5th Ave Ste 7530
NEW YORK
NEW YORK 10118-7501
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com